← FDA Drug Approvals (Drugs@FDA)

EVEROLIMUS

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: MYLAN · Approved 2019-04-19

Drug application

FDA Application #

ANDA210130

Application type

Abbreviated New Drug Application (Generic)

Brand name

EVEROLIMUS

Generic name

Everolimus

Active ingredients

EVEROLIMUS

Dosage form

TABLET, FOR SUSPENSION

Route

ORAL

Marketing status

Discontinued

Sponsor

MYLAN

First approval

2019-04-19

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown